How Canopy Growth Corporation stacks up

CGC · against 557 other Healthcare companies listed in US-listed

Profitability

27/ 100

Below the middle of the pack.

Ranked #277 of 558 · scores higher than 50% of peers

Bars: peers in each 10-point band of the profitability score

82 peers with a profitability score of 20–29, including CGC · Click a bar to see the companies

Why profitability scores 27?

Weighted metrics compared with all Healthcare companies.

Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.

a thinner operating margin: weaker than 80% of peers. Operating margin: -25.7% vs peer median 7.1%
a lower return on invested capital: weaker than 75% of peers. Return on invested capital: -11.7% vs peer median 4.7%
a lower return on assets: weaker than 69% of peers. Return on assets: -3.9% vs peer median 1.7%

Metric by metric

Position: dot = CGC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	CGC	Peer median	Better than	Weight
Return on invested capitalHigher is better · 517 reported	-11.7%	-7.0%	48%	33%
Operating marginHigher is better · 479 reported	-25.7%	-2.4%	36%	33%
Return on assetsHigher is better · 582 reported	-3.9%	-7.8%	56%	33%
Return on equityHigher is better · 531 reported	-39.5%	-19.7%	37%	Context only
Gross marginHigher is better · 601 reported	28.5%	43.9%	42%	Context only

Ranking by profitability score

Top 5 and the companies ranked around CGC

Rank	Company	Market cap	Profitability	Overall
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
1	CorMedix Inc.CRMD · US-listed	433M USD	99	81
1	Exelixis, Inc.EXEL · US-listed	17.9B USD	99	76
1	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	99	57
1	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
⋯
270	SIGA Technologies, Inc.SIGA · US-listed	223M USD	28	34
270	Supernus Pharmaceuticals, Inc.SUPN · US-listed	1.6B USD	28	48
270	Tarsus Pharmaceuticals, Inc.TARS · US-listed	3.4B USD	28	48
277	Azenta, Inc.AZTA · US-listed	1.6B USD	27	33
277	Canopy Growth CorporationCGC · US-listed	318M USD	27	26
277	Centene CorporationCNC · US-listed	33.3B USD	27	24
277	Relmada Therapeutics, Inc.RLMD · US-listed	455M USD	27	53
277	Neuronetics, Inc.STIM · US-listed	172M USD	27	34
282	Belite Bio, IncBLTE · US-listed	6.1B USD	26

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…